Jaen Juan C. — SEC Form 4 filings
SEC reporting owner CIK 1422996. 14 Form 4 filings on record with FilingPulse; latest filed 2026-07-13.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-01-25 to 2026-07-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 23 legs across 9 filings — 414,233 shares, $9,762,410 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 82,997 shares @ $24.71 ($2,050,599) in Arcus Biosciences, Inc., filed 2025-12-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | President | 14 | — | 23 legs · 414,233 sh · $9,762,410 | 8 |
Form 4 filings — Jaen Juan C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 48,502 @ $30.05 · Sale (S): 19,799 @ $28.61 · Sale (S): 268 @ $29.40 | EDGAR |
| 2026-06-24 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 9,236 @ $27.03 · Sale (S): 14,067 @ $27.69 · Sale (S): 1,697 @ $28.06 · Sale (S): 6,431 @ $29.66 | EDGAR |
| 2026-01-26 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 31,000 @ $0 · Grant/award (A): 126,000 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 29,670 @ $21.34 · Sale (S): 2,053 @ $22.34 · Sale (S): 100 @ $23.20 | EDGAR |
| 2025-12-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 11,225 @ $21.88 · Sale (S): 9,983 @ $22.16 | EDGAR |
| 2025-12-05 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 82,997 @ $24.71 | EDGAR |
| 2025-11-19 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 37,114 @ $20.23 · Sale (S): 7,836 @ $20.71 · Sale (S): 5,050 @ $19.75 | EDGAR |
| 2025-11-03 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 4,314 @ $20.32 | EDGAR |
| 2025-10-30 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 19,019 @ $20.19 · Sale (S): 47,675 @ $20.49 · Sale (S): 29,365 @ $21.53 · Sale (S): 800 @ $22.04 | EDGAR |
| 2025-01-27 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 50,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2024-12-17 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 17,286 @ $16.08 | EDGAR |
| 2024-06-18 | 4 | Arcus Biosciences, Inc. (RCUS) | Tax withholding (F): 6,969 @ $16.97 | EDGAR |
| 2024-02-28 | 4 | Arcus Biosciences, Inc. (RCUS) | Sale (S): 3,900 @ $20.06 · Sale (S): 23,132 @ $20.10 | EDGAR |
| 2024-01-25 | 4 | Arcus Biosciences, Inc. (RCUS) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 162,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1422996 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →